Correction
MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling
Paper Information
Record ID:
66517
Author(s):
Publication Date:
February 24, 2021
Retraction Date:
January 13, 2022
(3.9 years years ago)
Subjects:
Institutions:
- Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung 202, Taiwan
- Institute of Biopharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan
- Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei 112, Taiwan
- Division of Hemato-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung 204, Taiwan
- Department of Pathology, Chang Gung Memorial Hospital, Keelung 204, Taiwan
- Department of Radiology, Buddhist Tzu Chi General Hospital, Taichung Branch, Taichung 427, Taiwan
- School of Medicine, Tzu Chi University, Hualien 970, Taiwan
Country:
🇹🇼 TaiwanArticle Type:
Publisher:
MDPI
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Correction Details
Citations (45)
45
Total Citations31
Post-Retraction(68.9%)
10
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
12
Within 1 year
8
After 2+ years
1075
Days since retraction (latest)
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Unknown
Non-coding RNAs involved in the regulation of signaling pathways as possible markers of non-alcoholic fatty liver disease progression
Lyudmila Topchieva, G. A. Zhulay, И. В. Курбатова et al. (5 authors)
Известия Российской академии наук Серия биологическая
Published: Dec 2024
1075 days after retraction
MicroRNAs in Hepatocellular Carcinoma: Insights into Regulatory Mechanisms, Clinical Significance, and Therapeutic Potential
Fenfen Guo, Hong Li, Jingjing Wang et al. (8 authors)
Cancer Management and Research
Open Access
Published: Oct 2024
2 citations
2 citations
992 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Oct 2024
992 days after retraction
Non-Coding RNAs Involved in the Regulation of Signaling Pathways as Possible Markers of Non-Alcoholic Fatty Liver Disease Progression
Л. В. Топчиева, И. В. Курбатова, О. П. Дуданова et al. (5 authors)
Biology Bulletin
Published: Sep 2024
971 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Jun 2024
870 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Apr 2024
830 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Apr 2024
823 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Feb 2024
749 days after retraction
Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions
Aysan Moeinafshar, Mohammad Nouri, Nima Shokrollahi et al. (9 authors)
Cancer Cell International
Open Access
Published: Jan 2024
1 citation
1 citation
727 days after retraction
Detailed role of microRNA‐mediated regulation of PI3K/AKT axis in human tumors
Sulieman Ibraheem Shelash Al‐Hawary, Malika Ruzibakieva, Reena Gupta et al. (10 authors)
Cell Biochemistry and Function
Published: Dec 2023
4 citations
4 citations
702 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Sep 2023
618 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Sep 2023
596 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Aug 2023
567 days after retraction
Zebrafish facilitate non‐alcoholic fatty liver disease research: Tools, models and applications
Cheng Chang, Huicong Li, Ruilin Zhang
Liver International
Open Access
Published: Apr 2023
26 citations
26 citations
472 days after retraction
An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis et al. (11 authors)
International Journal of Molecular Sciences
Open Access
Published: Apr 2023
13 citations
13 citations
454 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Apr 2023
443 days after retraction
Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response
Milad Ashrafizadeh, Chakrabhavi Dhananjaya Mohan, Shobith Rangappa et al. (8 authors)
Medicinal Research Reviews
Published: Mar 2023
69 citations
69 citations
434 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Mar 2023
412 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Feb 2023
388 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Jan 2023
356 days after retraction
Role of microRNA in Endocrine Disruptor-Induced Immunomodulation of Metabolic Health
Nitya Shree, Zehuan Ding, Jodi A. Flaws et al. (4 authors)
Metabolites
Open Access
Published: Oct 2022
3 citations
3 citations
288 days after retraction
Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential
Han Qin, Mengchen Wang, Xi Dong et al. (6 authors)
Frontiers in Immunology
Open Access
Published: Oct 2022
24 citations
24 citations
270 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Sep 2022
247 days after retraction
Advances of cancer-associated fibroblasts in liver cancer
Hao Peng, Erwei Zhu, Yewei Zhang
Biomarker Research
Open Access
Published: Aug 2022
47 citations
47 citations
215 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Aug 2022
200 days after retraction
Cross-regulation between microRNAs and key proteins of signaling pathways in hepatocellular carcinoma
Haihong Hu, Tao‐Lan Zhang, Yiwen Wu et al. (6 authors)
Expert Review of Gastroenterology & Hepatology
Published: Jul 2022
182 days after retraction
Overexpression of circ <scp>PTK2</scp> suppresses the progression of nonalcoholic fatty liver disease via the <scp>miR</scp>‐200c/<scp>SIK2</scp>/<scp>PI3K</scp>/Akt axis
Yong Li, Chao‐Qun Cen, Бо Лю et al. (6 authors)
The Kaohsiung Journal of Medical Sciences
Open Access
Published: Jul 2022
2 citations
2 citations
174 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Jun 2022
139 days after retraction
The miR-216/miR-217 Cluster Regulates Lipid Metabolism in Laying Hens With Fatty Liver Syndrome via PPAR/SREBP Signaling Pathway
Lihui Zhu, Rongrong Liao, Jiwen Huang et al. (8 authors)
Frontiers in Veterinary Science
Open Access
Published: May 2022
8 citations
8 citations
138 days after retraction
Role of Exosomes in Chronic Liver Disease Development and Their Potential Clinical Applications
Chen Wang, Jinwen Liu, Yongmin Yan et al. (4 authors)
Journal of Immunology Research
Open Access
Published: May 2022
29 citations
29 citations
113 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Apr 2022
84 days after retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Jan 2022
Same day as retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Dec 2021
38 days before retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Nov 2021
68 days before retraction
Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer
Po-Shuan Huang, Chia‐Jung Liao, Ya‐Hui Huang et al. (8 authors)
Cancers
Open Access
Published: Oct 2021
17 citations
17 citations
79 days before retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Aug 2021
164 days before retraction
Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA
Tomoko Tadokoro, Asahiro Morishita, Tsutomu Masaki
International Journal of Molecular Sciences
Open Access
Published: Jul 2021
61 citations
61 citations
168 days before retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Jul 2021
171 days before retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Jul 2021
171 days before retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Jul 2021
182 days before retraction
Paper citing MicroRNA-21 Plays Multiple Oncometabolic Roles in ...
Unknown Authors
Unknown Journal
Published: Jul 2021
194 days before retraction
MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma
Laura Gramantieri, Catia Giovannini, Fabio Piscaglia et al. (4 authors)
Journal of Hepatocellular Carcinoma
Open Access
Published: May 2021
25 citations
25 citations
257 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #66516
Apr 22, 2024Quick Stats
Total Citations:
45
Years Since Retraction:
3.9 years
Open Access:
Yes
Last Checked:
Never